MedTrace Logo

Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation

NCT05398991 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-03-21

No results posted yet for this study

Summary

A clinical trial of Coronary Covered Stents System for the treatment of coronary artery perforation.

Conditions

  • Coronary Artery Perforation

Interventions

DEVICE

the Coronary Covered Stents System manufactured by Shanghai MicroPort Medical (Group) Co., Ltd.

the Coronary Covered Stents System contains a covered stent and a delivery system

Sponsors & Collaborators

  • Shanghai MicroPort Rhythm MedTech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Qian Tong, M.D. · The First Hospital of Jilin University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-26
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398991 on ClinicalTrials.gov